Skip to content

Detection of new biomarker for genitourinary diseases by metabolomics

Detection of new biomarker for genitourinary diseases by metabolomics - Detection of new biomarker in blood and urine for genitourinary diseases by metabolomics

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000030447
Enrollment
100
Registered
2017-12-25
Start date
2017-06-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

genitourinary diseases

Interventions

None listed

Sponsors

Tohoku University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Normal volunteers and patients with genitourinary diseases (kidney cancer, prostate cancer, bladder cancer, tesuticular cancer and adrenal tumors) who approved storing thier blood and urine for our studies

Exclusion criteria

Exclusion criteria: Those who did not approve storing thier blood and urine for our studies

Design outcomes

Primary

MeasureTime frame
Comparison of metabolites including blood and urine with normal volunteers and patients with genitourinary diseases

Countries

Japan

Contacts

Public ContactYoshhide Kawasaki

Tohoku University Graduate School of Medicine Department of Urology

kawasaki@uro.med.tohoku.ac.jp022-717-7278

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026